Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longtin

Showing results (411-420 of 434) with videos related to

Pageof 44
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2018
Clostridium difficile: Investigating Transmission Patterns Between Infected and Colonized Patients Using Whole Genome SequencingLing Yuan Kong, David W Eyre, Jacques Corbeil, et al.
JMIR Research Protocols|December 7, 2023
Postpandemic Evaluation of the Eco-Efficiency of Personal Protective Equipment Against COVID-19 in Emergency Departments: Proposal for a Mixed Methods StudySimon Berthelot, Yves Longtin, Manuele Margni, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2023
Plasmid genomic epidemiology of <i>bla</i><sub>KPC</sub> carbapenemase-producing <i>Enterobacterales</i> in Canada, 2010-2021Nicole Lerminiaux, Robyn Mitchell, Jessica Bartoszko, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 8, 2024
Nirmatrelvir-ritonavir use among adults hospitalized with COVID-19 during the Omicron phase of the COVID-19 pandemic, Canadian Nosocomial Infection Surveillance ProgramRobyn Mitchell, Diane Lee, Linda Pelude, et al.
JAMA Network Open|February 27, 2026
Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical TrialEmily G McDonald, Guillaume Butler-Laporte, James M Brophy, et al.
Trials|July 9, 2026
Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trialConnor Prosty, Alex Carignan, Adrienne K Chan, et al.
JAMA Network Open|April 20, 2023
Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022Robyn Mitchell, Joelle Cayen, Nisha Thampi, et al.
Antimicrobial Resistance and Infection Control|July 12, 2025
The evolving epidemiology of Carbapenemase-producing Enterobacterales in Canadian acute care facilities, 2010-2023Robyn Mitchell, Laura Mataseje, Joëlle Cayen, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Cost-effective solutions for high-throughput enzymatic DNA methylation sequencingAmy Longtin, Marina M Watowich, Baptiste Sadoughi, et al.
Diagnostic Microbiology and Infectious Disease|August 23, 2021
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratoriesDerek R Stein, Carla Osiowy, Ainsley Gretchen, et al.
Pageof 44

Showing results (411-420 of 434) with videos related to

Sort By:
Pageof 44
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2018
Clostridium difficile: Investigating Transmission Patterns Between Infected and Colonized Patients Using Whole Genome SequencingLing Yuan Kong, David W Eyre, Jacques Corbeil, et al.
JMIR Research Protocols|December 7, 2023
Postpandemic Evaluation of the Eco-Efficiency of Personal Protective Equipment Against COVID-19 in Emergency Departments: Proposal for a Mixed Methods StudySimon Berthelot, Yves Longtin, Manuele Margni, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2023
Plasmid genomic epidemiology of <i>bla</i><sub>KPC</sub> carbapenemase-producing <i>Enterobacterales</i> in Canada, 2010-2021Nicole Lerminiaux, Robyn Mitchell, Jessica Bartoszko, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 8, 2024
Nirmatrelvir-ritonavir use among adults hospitalized with COVID-19 during the Omicron phase of the COVID-19 pandemic, Canadian Nosocomial Infection Surveillance ProgramRobyn Mitchell, Diane Lee, Linda Pelude, et al.
JAMA Network Open|February 27, 2026
Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical TrialEmily G McDonald, Guillaume Butler-Laporte, James M Brophy, et al.
Trials|July 9, 2026
Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trialConnor Prosty, Alex Carignan, Adrienne K Chan, et al.
JAMA Network Open|April 20, 2023
Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022Robyn Mitchell, Joelle Cayen, Nisha Thampi, et al.
Antimicrobial Resistance and Infection Control|July 12, 2025
The evolving epidemiology of Carbapenemase-producing Enterobacterales in Canadian acute care facilities, 2010-2023Robyn Mitchell, Laura Mataseje, Joëlle Cayen, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Cost-effective solutions for high-throughput enzymatic DNA methylation sequencingAmy Longtin, Marina M Watowich, Baptiste Sadoughi, et al.
Diagnostic Microbiology and Infectious Disease|August 23, 2021
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratoriesDerek R Stein, Carla Osiowy, Ainsley Gretchen, et al.
Pageof 44